Rutherford Health

Last updated

Rutherford Health was a private oncology provider founded by Mike Moran and Karol Sikora in 2015, with investment from Neil Woodford and the Wales Life Sciences Investment Fund, to develop proton therapy facilities in the United Kingdom and elsewhere. Until 2019 it was known as Proton Partners International. [1]

Contents

It went into liquidation in June 2022. [2] [3] According to major shareholder Schroders UK Public Private Trust, the company had pursued a "flawed expansion strategy ... from 2015 to 2019" leading to "a high and unsustainable cash burn". [4] [5] [6]

Proton therapy

Rutherford Health ran proton therapy centres in Newport, Wales, Bedlington, Northumberland, Liverpool and Reading, Berkshire. Equipment and services were provided by Ion Beam Applications, [7] [8] Philips and Elekta. The Newport site was the first to open with construction starting in 2016. [9] The Reading site cost £30 million and work began in December 2016, [10] before opening in October 2018. [11] The Bedlington site was opened in 2018. [12]

Funding included £10 million from the Wales Life Sciences Investmunt Fund in 2016, [13] as well as continued investment of over £100 million through fund manager Neil Woodford. [14] The Wales Audit Office criticised handling of the Wales Life Sciences Investment Fund due to Woodford being the company's main shareholder. [15] Proton Partners secured £30 million from Shawbrook Bank in January 2016 which it later repaid in full in 2019. [16] The Northumberland site benefited from a grant of £450,000 from the Let’s Grow regional growth fund programme. [17]

In November 2016 Proton Partners purchased the Gulf International Cancer Centre in Abu Dhabi as part of plans to create the first proton beam therapy treatment centre in the United Arab Emirates. [18] Work began in 2019. [19]

In March 2017, the company announced the development of its fourth UK centre to be built by Interserve on the Knowledge Quarter site in Liverpool The centre was completed in 2020 and is now fully operational. [20] In 2018 it was announced that work had started on a headquarters for their Rutherford Diagnostics subsidiary. The building was to serve as a research centre, sited next to their Liverpool cancer treatment centre. [21]

Other activities

Proton Partners International incorporated five companies in total, including Rutherford Estates, Rutherford Innovations and Rutherford Diagnostics. In July 2020, the Company launched a membership scheme, "Rutherford Direct" aimed at providing a "cancer only plan" to companies and individuals as an insurance in case of a cancer diagnosis.

In June 2020, Rutherford Health partnered with Panthera Biopartners to set up a network of clinical trial sites. Under the name "Panthera@theRutherford", clinical oncology trials were to be undertaken at Rutherford sites, utilising Panthera's "clinical trial management experience". [22] [23]

In September 2021 Michael Richards opened the first community diagnostic centre in England, on the outskirts of Taunton, to be operated by Rutherford Health in partnership with Somerset NHS Foundation Trust. [24] The trust was to pay a "tariff price" for the service and was reimbursed for the use of its staff. [25]

See also

Related Research Articles

<span class="mw-page-title-main">Radiation therapy</span> Therapy using ionizing radiation, usually to treat cancer

Radiation therapy or radiotherapy is a treatment using ionizing radiation, generally provided as part of cancer therapy to either kill or control the growth of malignant cells. It is normally delivered by a linear particle accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body, and have not spread to other parts. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor. Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. A physician who practices in this subspecialty is a radiation oncologist.

<span class="mw-page-title-main">Roche</span> Swiss multinational healthcare company

F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.

<span class="mw-page-title-main">TRIUMF</span> Particle physics laboratory in Canada

TRIUMF is Canada's national particle accelerator centre. It is considered Canada's premier physics laboratory, and consistently regarded as one of the world's leading subatomic physics research centres. Owned and operated by a consortium of universities, it is on the south campus of one of its founding members, the University of British Columbia in Vancouver, British Columbia, Canada. It houses the world's largest normal conducting cyclotron, a source of 520 MeV protons, which was named an IEEE Milestone in 2010. Its accelerator-focused activities involve particle physics, nuclear physics, nuclear medicine, materials science, and detector and accelerator development.

<span class="mw-page-title-main">Proton therapy</span> Medical Procedure

In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.

<span class="mw-page-title-main">Varian Medical Systems</span> American healthcare company

Varian Medical Systems is an American radiation oncology treatments and software maker based in Palo Alto, California. Their medical devices include linear accelerators (LINACs) and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies software for managing cancer clinics, radiotherapy centers, and medical oncology practices. Varian Medical Systems employs more than 7,100 people at manufacturing sites in North America, Europe, and China and approximately 70 sites globally.

<span class="mw-page-title-main">Apollo Hospitals</span> Indian hospital chain

Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the largest for-profit private hospital network in India, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries.

Shaukat Khanum Memorial Cancer Hospital and Research Centre(Urdu: یادگاری اسپتالِ شوکت خانم برائے معالجہ و تحقیقِ سرطان, abbreviated as SKMCH&RC/SKMCH) is a cancer centre with locations in Lahore and Peshawar, Pakistan. It is the first project of the Shaukat Khanum Memorial Trust, a charitable organization established under the Societies Registration Act XXI of 1858 of British India. It is Pakistan's largest tertiary care hospital.

Southampton General Hospital (SGH) is a large teaching hospital in Southampton, Hampshire, England run by University Hospital Southampton NHS Foundation Trust.

Sir Christopher Thomas Evans is a Welsh professor, scientist and biotechnology entrepreneur. Evans is known for founding and co-founding numerous successful biotech companies in the United Kingdom.

<span class="mw-page-title-main">Fast neutron therapy</span>

Fast neutron therapy utilizes high energy neutrons typically between 50 and 70 MeV to treat cancer. Most fast neutron therapy beams are produced by reactors, cyclotrons (d+Be) and linear accelerators. Neutron therapy is currently available in Germany, Russia, South Africa and the United States. In the United States, one treatment center is operational, in Seattle, Washington. The Seattle center uses a cyclotron which produces a proton beam impinging upon a beryllium target.

Particle therapy is a form of external beam radiotherapy using beams of energetic neutrons, protons, or other heavier positive ions for cancer treatment. The most common type of particle therapy as of August 2021 is proton therapy.

University College London Hospitals NHS Foundation Trust (UCLH) is an NHS foundation trust based in London, United Kingdom. It comprises University College Hospital, University College Hospital at Westmoreland Street, the UCH Macmillan Cancer Centre, the Royal National ENT and Eastman Dental Hospitals, the Hospital for Tropical Diseases, the National Hospital for Neurology and Neurosurgery, the Royal London Hospital for Integrated Medicine and the Royal National Throat, Nose and Ear Hospital.

<span class="mw-page-title-main">Knowledge Quarter, Liverpool</span> District of Liverpool city centre focus on the education, research and science sectors

The "Knowledge Quarter" in Liverpool, England is a modern term in business given to the vicinity of Liverpool city centre that focuses heavily on the education, knowledge and research sectors.

<span class="mw-page-title-main">Moderna</span> American biotechnology company

Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

<span class="mw-page-title-main">Clatterbridge Cancer Centre NHS Foundation Trust</span> UK public sector healthcare provider

The Clatterbridge Cancer Centre is an NHS Foundation Trust, which specialises in the treatment of cancer. The centre is one of several specialist hospitals located within Merseyside; alongside Liverpool Heart and Chest Hospital, Alder Hey Children's Hospital, Liverpool Women's Hospital, and the Walton Centre.

<span class="mw-page-title-main">Christie Hospital</span> Hospital in Manchester, England

The Christie Hospital in Manchester, England, is one of the largest cancer treatment centres in Europe. It is managed by The Christie NHS Foundation Trust.

<span class="mw-page-title-main">Lagos University Teaching Hospital</span> Hospital in Lagos, Nigeria

Lagos University Teaching Hospital (LUTH) is a tertiary hospital established in 1961 and is located in Idi-Araba, Surulere, Lagos State, the administrative division of Nigeria. The teaching hospital affiliated with the University of Lagos College of Medicine established in 1962. The University of Lagos College of Medicine educates students and LUTH provides them with experience through placement and work experience.

The case of Ashya King concerns a boy named Ashya King, who had a brain tumour. His parents, Brett and Naghemeh King, took their son out of Southampton General Hospital (England) in August 2014 over a disagreement with doctors regarding his treatment.

<span class="mw-page-title-main">Seattle Cancer Care Alliance</span> Cancer treatment and research center in Seattle, U.S.

Seattle Cancer Care Alliance (SCCA) is a cancer treatment and research center in Seattle, Washington. Established in 1998, this nonprofit provides clinical oncology care for patients treated at its three partner organizations: Fred Hutchinson Cancer Research Center, Seattle Children's and UW Medicine. Together, these four institutions form the Fred Hutch/University of Washington Cancer Consortium.

<span class="mw-page-title-main">Bhagwan Mahaveer Cancer Hospital and Research Centre</span> Hospital in Rajasthan, India

The Bhagwan Mahaveer Cancer Hospital and Research Centre (BMCHRC) is located in Jawahar Lal Nehru Marg, Bajaj Nagar, Jaipur, Rajasthan. It is also popularly known as BMCHRC. The hospital is NABH and NABL accredited super speciality cancer treatment centre. The hospital is following international protocol for cancer treatment managed by K.G. Kothari Memorial Trust. The centre is committed to providing comprehensive care along with prevention and research in cancer.

References

  1. ↑ "Rutherford Health PLC - Overview". Companies House. Retrieved 11 June 2020.
  2. ↑ Wise, Jacqui (6 June 2022). "Private cancer provider collapses despite drive to tackle NHS backlog". BMJ. pp. o1401. doi:10.1136/bmj.o1401.
  3. ↑ "Staff "devastated" after Rutherford Health liquidation". Society of Radiographers . 6 June 2022.
  4. ↑ "Rutherford Health preparation to wind-up". Association of Investment Companies . Schroder UK Public Private Trust. 6 June 2022.
  5. ↑ Carding, Nick (6 June 2022). "Cancer provider collapses despite NHS catch-up drive" . Health Service Journal. Retrieved 7 June 2022.
  6. ↑ Kilgannon, Laurence (6 June 2022). "Rutherford Health makes preparations to wind-up". Insider Media.
  7. ↑ "BRIEF-Ion Beam Applications signs two contracts with Proton Partners International". Reuters. 13 December 2016. Retrieved 24 December 2016.
  8. ↑ "Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment". News medical. 9 December 2016. Retrieved 24 December 2016.
  9. ↑ "Construction begins on UK's first proton beam therapy cancer treatment centre". Wales on line. 18 January 2016. Retrieved 24 December 2016.
  10. ↑ "GRAHAM Construction starts work on £30m cancer centre in Reading". Builder and Engineer. 16 December 2016. Archived from the original on 2016-12-24. Retrieved 24 December 2016.
  11. ↑ "Reading: Cancer treatment centre opens at Thames Valley Science Park". The Business Magazine. 3 October 2018. Retrieved 19 October 2018.
  12. ↑ "Cancer-therapy centre opens in Northumberland". Northumberland Gazette. 21 August 2018.
  13. ↑ Barry, Sion (6 April 2015). "£10m Welsh Government backing for UK's first proton beam centres". WalesOnline.
  14. ↑ Powell, Jamie (4 July 2019). "Proton Partners and Woodford: a valuation puzzle". FT Alphaville. Financial Times.
  15. ↑ Davies, Paul (25 June 2019). "Plenary". Record of Proceedings. Welsh Parliament . Retrieved 27 April 2021.
  16. ↑ "Neil Woodford-backed Proton Partners International receives £30m loan from Shawbrook bank to fund development of three proton therapy centres". City AM. 6 January 2016. Retrieved 24 December 2016.
  17. ↑ "Cancer treatment centre in Northumberland backed with grant from Journal's Let's Grow fund". Chronicle Live. 18 July 2016. Retrieved 24 December 2016.
  18. ↑ "PROTON THERAPY CENTRE FOR ABU DHABI". International medical Travel Journal. 25 November 2016. Retrieved 24 December 2016.
  19. ↑ Harley, Nicky (5 June 2019). "Cancer centre not affected by investment fund's woes". The National.
  20. ↑ Houghton, Alistair (15 March 2017). "New £35m cancer centre will offer life saving proton beam therapy". liverpoolecho. Retrieved 19 October 2018.
  21. ↑ Houghton, Alistair (19 October 2018). "Watch amazing fly-through video of BILLION-pound Paddington Village". Liverpool Echo. Retrieved 19 October 2018.
  22. ↑ Spinner, Jenni (13 July 2020). "Panthera, Rutherford Health launch oncology trial network". Outsourcing-Pharma.
  23. ↑ Nolan, Laura (28 October 2021). "Middlesbrough man first to trial new cancer drug". The Northern Echo.
  24. ↑ Jones, Jamie (1 October 2021). "New state-of-the-art diagnostic centre opens in Taunton". Somerset County Gazette.
  25. ↑ "Trust says 'game-changing' deal will expand capacity by 25pc". Health Service Journal. 8 October 2021. Retrieved 9 October 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.